Capital Wealth Planning LLC lowered its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 95.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,455 shares of the healthcare conglomerate’s stock after selling 143,278 shares during the period. UnitedHealth Group makes up about 1.2% of Capital Wealth Planning LLC’s investment portfolio, making the stock its 17th largest position. Capital Wealth Planning LLC’s holdings in UnitedHealth Group were worth $1,460,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the second quarter worth $110,000. Bruderman Asset Management LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its stake in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth $121,000. Finally, Acrospire Investment Management LLC increased its stake in shares of UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after buying an additional 400 shares during the last quarter. Institutional investors own 86.24% of the company’s stock.

A number of research firms have commented on UNH. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a report on Saturday, January 20th. Argus lifted their price objective on shares of UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 18th. Deutsche Bank lifted their price objective on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Citigroup lifted their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and issued a $259.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $243.22.

In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. Insiders sold 53,853 shares of company stock valued at $12,358,508 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (UNH) opened at $216.46 on Friday. The stock has a market cap of $209,760.00, a price-to-earnings ratio of 20.21, a PEG ratio of 1.31 and a beta of 0.70. UnitedHealth Group Inc has a 1-year low of $156.49 and a 1-year high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.11 earnings per share. sell-side analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was first published by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.dailypolitical.com/2018/02/09/capital-wealth-planning-llc-has-1-46-million-stake-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.